Skip to content
10-Q

Quarterly Report

Concentrix SREV, Inc.

0001310114-21-000024

← back to feed
Filed
Apr 28, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 23, 2021 97.35M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $34.17M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $34.01M
Current Liabilities Q1 2021 · Mar 31, 2021 $49.38M
Current Liabilities Q1 2021 · Dec 31, 2020 $49.77M
Total Liabilities Q1 2021 · Mar 31, 2021 $75.43M
Total Liabilities Q1 2021 · Dec 31, 2020 $77.34M
Current Assets Q1 2021 · Mar 31, 2021 $79.63M
Current Assets Q1 2021 · Dec 31, 2020 $82.17M
Total Assets Q1 2021 · Mar 31, 2021 $144.81M
Total Assets Q1 2021 · Dec 31, 2020 $152.61M
Shares Diluted Q1 2021 · Mar 31, 2020 94.97M sh
Capex Q1 2021 · Mar 31, 2020 $1.56M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$5.67M
Stockholders Equity Q1 2021 · Mar 31, 2020 $84.14M
Stockholders Equity Q1 2021 · Dec 31, 2019 $88.44M
Eps Diluted Q1 2021 · Mar 31, 2020 −$0.06
Eps Basic Q1 2021 · Mar 31, 2020 −$0.06
Sga Expense Q1 2021 · Mar 31, 2020 $10.69M
Rd Expense Q1 2021 · Mar 31, 2020 $1.18M
Net Income Q1 2021 · Mar 31, 2020 −$5.94M
Operating Income Q1 2021 · Mar 31, 2020 −$5.05M
Gross Profit Q1 2021 · Mar 31, 2020 $14.55M
Cost Of Revenue Q1 2021 · Mar 31, 2020 $35.56M
Revenue Q1 2021 · Mar 31, 2020 $50.11M